Prothena | Bienes





Bienes Cambio Fecha
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Akebia Therapeutics USD 364.15M 18.56M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Prothena USD 352.63M 46.44M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xoma USD 263.15M 39.7M 2025-09


Prothena Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.